Tan Ying-Cai, Blumenfeld Jon, Rennert Hanna
Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY 10065, USA.
Biochim Biophys Acta. 2011 Oct;1812(10):1202-12. doi: 10.1016/j.bbadis.2011.03.002. Epub 2011 Mar 17.
Autosomal dominant polycystic kidney disease (ADPKD) is a common, monogenic multi-systemic disorder characterized by the development of renal cysts and various extrarenal manifestations. Worldwide, it is a common cause of end-stage renal disease. ADPKD is caused by mutation in either one of two principal genes, PKD1 and PKD2, but has large phenotypic variability among affected individuals, attributable to PKD genic and allelic variability and, possibly, modifier gene effects. Recent studies have generated considerable information regarding the genetic basis and molecular diagnosis of this disease, its pathogenesis, and potential strategies for targeted treatment. The purpose of this article is to provide a comprehensive review of the genetics of ADPKD, including mechanisms responsible for disease development, the role of gene variations and mutations in disease presentation, and the putative role of microRNAs in ADPKD etiology. The emerging and important role of genetic testing and the advent of novel molecular diagnostic applications also are reviewed. This article is part of a Special Issue entitled: Polycystic Kidney Disease.
常染色体显性多囊肾病(ADPKD)是一种常见的单基因多系统疾病,其特征是肾囊肿的形成以及各种肾外表现。在全球范围内,它是终末期肾病的常见病因。ADPKD由两个主要基因PKD1和PKD2中的任何一个发生突变引起,但在受影响个体中具有很大的表型变异性,这归因于PKD基因和等位基因的变异性,以及可能的修饰基因效应。最近的研究已经产生了关于这种疾病的遗传基础、分子诊断、发病机制以及靶向治疗潜在策略的大量信息。本文的目的是对ADPKD的遗传学进行全面综述,包括疾病发展的机制、基因变异和突变在疾病表现中的作用,以及微小RNA在ADPKD病因学中的假定作用。还综述了基因检测的新兴重要作用以及新型分子诊断应用的出现。本文是名为“多囊肾病”的特刊的一部分。